| Financial Year |
March 31 2023 |
| Monetary Funds |
1,624,310,541.31 |
| Held-for-trading Financial Assets |
30,000,000.00 |
| Notes Receivable |
38,268,257.63 |
| Accounts Receivable |
88,648,652.43 |
| Advances to Suppliers |
15,193,252.07 |
| Other Receivables |
3,570,645.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
164,854,744.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,758,475.51 |
| Total Current Assets |
1,968,913,650.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,988,270.17 |
| Investment Properties |
233,049,913.23 |
| Fixed Assetes |
324,075,380.76 |
| Under-construction Projects |
175,833,844.07 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
35,547,451.36 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
95,758,062.22 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
50,259,527.03 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
6,706,561.86 |
| Sub-Total of Non-Current Assets |
1,015,937,901.80 |
| Total Assets |
2,984,851,552.15 |
| Short-Term Loans |
342,272,264.92 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
145,923,748.34 |
| Accounts Received In Advance |
1,632,616.53 |
| Employee Compensation Payable |
19,201,537.97 |
| Taxes Payable |
4,714,562.69 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,573,492.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,468,887.74 |
| Other Current Liabilities |
986,579.97 |
| Sub-Total of Current Liabilities |
531,550,902.54 |
| Long-term Loans |
-- |
| Bonds Payable |
419,673,243.73 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,137,525.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
479,396,109.17 |
| Total Liabilities |
1,010,947,011.71 |
| Paid-In Capital(Or Share Stock) |
197,205,516.00 |
| Capital Surplus |
856,301,875.63 |
| Surplus Reserve |
92,684,202.51 |
| LESS:Treasury Stock |
165,106,271.22 |
| Undistributed Profits |
878,378,339.16 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,973,904,540.44 |
| Owner's Equity（Stockholder's Equity） |
1,973,904,540.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,984,851,552.15 |
